Related references
Note: Only part of the references are listed.Anti-inflammatory role of tempol (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl) in nephroprotection
M. A. Afjal et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2019)
An Early Decrease in Release of Aquaporin-2 in Urinary Extracellular Vesicles After Cisplatin Treatment in Rats
Hiroko Sonoda et al.
CELLS (2019)
Neuroprotective effect of N-acetylcysteine against cisplatin-induced toxicity in rat brain by modulation of oxidative stress and inflammation
Wessam M. Abdel-Wahab et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Protective effects of zingerone on cisplatin-induced nephrotoxicity in female rats
Fatih Mehmet Kandemir et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2019)
Aquaporins in Renal Diseases
Jinzhao He et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity
Vladislav Volarevic et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy
Blessy George et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
S-allyl cysteine ameliorates cyclophosphamide-induced downregulation of urothelial uroplakin IIIa with a concomitant effect on expression and release of CCL11 and TNF-α in mice
Sayed Aliul Hasan Abdi et al.
PHARMACOLOGICAL REPORTS (2018)
Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding
Hitesh Soni et al.
RENAL FAILURE (2018)
Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges
Martina Perse et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Nephrotoxicity Evidence in patients receiving cisplatin therapy
Elizabeth A. Duffy et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2018)
The superoxide dismutase mimetic tempol blunts diabetes-induced upregulation of NADPH oxidase and endoplasmic reticulum stress in a rat model of diabetic nephropathy
Miles J. De Blasio et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury
Wei Yan et al.
FREE RADICAL RESEARCH (2017)
Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection
Blanca Humanes et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Tempol, a Superoxide Dismutase Mimetic Agent, Inhibits Superoxide Anion-Induced Inflammatory Pain in Mice
Catia C. F. Bernardy et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Bryan Oronsky et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
L-Carnitine Ameliorates the Decrease of Aquaporin 2 Levels in Rats with Cisplatin-Induced Kidney Injury
Jianjun Gao et al.
NEPHRON (2017)
Dichloroacetate Prevents Cisplatin-Induced Nephrotoxicity without Compromising Cisplatin Anticancer Properties
Ramindhu Galgamuwa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Effects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy
Danijela Karanovic et al.
PLOS ONE (2016)
Protective Effect of Tempol against Cisplatin-Induced Ototoxicity
Cha Kyung Youn et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Epigallocatechin-3-gallate protects against cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis
Binbin Chen et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Tempol prevents genotoxicity induced by vorinostat: role of oxidative DNA damage
Karem H. Alzoubi et al.
CYTOTECHNOLOGY (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Tempol, a Superoxide Dismutase Mimetic Agent, Ameliorates Cisplatin-Induced Nephrotoxicity through Alleviation of Mitochondrial Dysfunction in Mice
Lamiaa A. Ahmed et al.
PLOS ONE (2014)
Estradiol and Testosterone Regulate Arginine-Vasopressin Expression in SH-SY5Y Human Female Neuroblastoma Cells Through Estrogen Receptors-α and -β
Daniela Grassi et al.
ENDOCRINOLOGY (2013)
Acute kidney injury: an increasing global concern
Norbert H. Lameire et al.
LANCET (2013)
Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice
Annelies A. van Angelen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells
So-Jung Sohn et al.
TOXICOLOGY LETTERS (2013)
Mechanisms of Cisplatin Nephrotoxicity
Ronald P. Miller et al.
TOXINS (2010)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more
Joseph V. Bonventre
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury
P. L. Zhang et al.
KIDNEY INTERNATIONAL (2008)
Cisplatin: a review of toxicities and therapeutic applications
K. Barabas et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2008)
Cisplatin nephrotoxicity: A review
Xin Yao et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
Butein ameliorates renal concentrating ability in cisplatin-induced acute renal failure in rats
DG Kang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Superoxide dismustase mimetic tempol decreases blood pressure by increasing renal medullary blood flow in hyperinsulinemic-hypertensive rats
S Onuma et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Physiological effects of vasopressin and atrial natriuretic peptide in the collecting duct
T Inoue et al.
CARDIOVASCULAR RESEARCH (2001)
Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria
BK Kishore et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
